158 related articles for article (PubMed ID: 9048231)
1. Ifosfamide metabolite chloroacetaldehyde causes renal dysfunction in vivo.
Springate JE
J Appl Toxicol; 1997; 17(1):75-9. PubMed ID: 9048231
[TBL] [Abstract][Full Text] [Related]
2. Toxicity of ifosfamide and its metabolite chloroacetaldehyde in cultured renal tubule cells.
Springate J; Chan K; Lu H; Davies S; Taub M
In Vitro Cell Dev Biol Anim; 1999 Jun; 35(6):314-7. PubMed ID: 10476917
[TBL] [Abstract][Full Text] [Related]
3. Comparative toxicity of ifosfamide metabolites and protective effect of mesna and amifostine in cultured renal tubule cells.
Zaki EL; Springate JE; Taub M
Toxicol In Vitro; 2003 Aug; 17(4):397-402. PubMed ID: 12849722
[TBL] [Abstract][Full Text] [Related]
4. Ifosfamide toxicity in cultured proximal renal tubule cells.
Springate J; Taub M
Pediatr Nephrol; 2007 Mar; 22(3):358-65. PubMed ID: 17072651
[TBL] [Abstract][Full Text] [Related]
5. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Pediatr Nephrol; 2008 Apr; 23(4):611-8. PubMed ID: 18204866
[TBL] [Abstract][Full Text] [Related]
6. Human kidney tubules detoxify chloroacetaldehyde, a presumed nephrotoxic metabolite of ifosfamide.
Dubourg L; Michoudet C; Cochat P; Baverel G
J Am Soc Nephrol; 2001 Aug; 12(8):1615-1623. PubMed ID: 11461933
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, mesna, and nephrotoxicity in children.
Skinner R; Sharkey IM; Pearson AD; Craft AW
J Clin Oncol; 1993 Jan; 11(1):173-90. PubMed ID: 8418231
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide metabolite chloroacetaldehyde causes Fanconi syndrome in the perfused rat kidney.
Zamlauski-Tucker MJ; Morris ME; Springate JE
Toxicol Appl Pharmacol; 1994 Nov; 129(1):170-5. PubMed ID: 7974492
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide induced depletion of glutathione in human peripheral blood lymphocytes and protection by mesna.
Meier T; Allenbacher A; Mueller E; Multhoff G; Botzler C; Wiesnet M; Issels R
Anticancer Drugs; 1994 Aug; 5(4):403-9. PubMed ID: 7949243
[TBL] [Abstract][Full Text] [Related]
10. Ifosfamide and mesna: effects on the Na/H exchanger activity in renal epithelial cells in culture (LLC-PK1).
Mohrmann M; Küpper N; Schönfield B; Brandis M
Ren Physiol Biochem; 1995; 18(3):118-27. PubMed ID: 7542792
[TBL] [Abstract][Full Text] [Related]
11. Evidence of renal metabolism of ifosfamide to nephrotoxic metabolites.
Woodland C; Ito S; Granvil CP; Wainer IW; Klein J; Koren G
Life Sci; 2000 Nov; 68(1):109-17. PubMed ID: 11132240
[TBL] [Abstract][Full Text] [Related]
12. Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells.
Patzer L; Hernando N; Ziegler U; Beck-Schimmer B; Biber J; Murer H
Kidney Int; 2006 Nov; 70(10):1725-34. PubMed ID: 17003823
[TBL] [Abstract][Full Text] [Related]
13. Targets of chloroacetaldehyde-induced nephrotoxicity.
Knouzy B; Dubourg L; Baverel G; Michoudet C
Toxicol In Vitro; 2010 Feb; 24(1):99-107. PubMed ID: 19733226
[TBL] [Abstract][Full Text] [Related]
14. Renal-tubule metabolism of ifosfamide to the nephrotoxic chloroacetaldehyde: pharmacokinetic modeling for estimation of intracellular levels.
Aleksa K; Ito S; Koren G
J Lab Clin Med; 2004 Mar; 143(3):159-62. PubMed ID: 15007305
[TBL] [Abstract][Full Text] [Related]
15. Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
Pendyala L; Creaven PJ; Schwartz G; Meropol NJ; Bolanowska-Higdon W; Zdanowicz J; Murphy M; Perez R
Clin Cancer Res; 2000 Apr; 6(4):1314-21. PubMed ID: 10778956
[TBL] [Abstract][Full Text] [Related]
16. Chloroacetaldehyde as a sulfhydryl reagent: the role of critical thiol groups in ifosfamide nephropathy.
Benesic A; Schwerdt G; Freudinger R; Mildenberger S; Groezinger F; Wollny B; Kirchhoff A; Gekle M
Kidney Blood Press Res; 2006; 29(5):280-93. PubMed ID: 17035713
[TBL] [Abstract][Full Text] [Related]
17. Ifosfamide-induced nephrotoxicity: mechanism and prevention.
Nissim I; Horyn O; Daikhin Y; Nissim I; Luhovyy B; Phillips PC; Yudkoff M
Cancer Res; 2006 Aug; 66(15):7824-31. PubMed ID: 16885387
[TBL] [Abstract][Full Text] [Related]
18. Investigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver-kidney microfluidic data and pharmacokinetic-system biology models.
Leclerc E; Hamon J; Bois FY
J Appl Toxicol; 2016 Feb; 36(2):330-9. PubMed ID: 26152902
[TBL] [Abstract][Full Text] [Related]
19. Mesna excretion and ifosfamide nephrotoxicity in children.
Goren MP; Pratt CB; Meyer WH; Wright RK; Dodge RK; Viar MJ
Cancer Res; 1989 Dec; 49(24 Pt 1):7153-7. PubMed ID: 2510931
[TBL] [Abstract][Full Text] [Related]
20. Renal ontogeny of ifosfamide nephrotoxicity.
Aleksa K; Halachmi N; Ito S; Koren G
J Lab Clin Med; 2004 Dec; 144(6):285-93. PubMed ID: 15614250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
